Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1	0	4	49	181	231
Market Cap Growth	-81.76%	-91.78%	-92.38%	-72.70%	-21.88%	152.15%
Enterprise Value	42	43	72	157	218	216
PE Ratio	-	0.01	-0.05	-0.24	-1.27	-2.89
PS Ratio	0.04	0.02	0.22	5.99	405.27	-
PB Ratio	-0.01	0.00	-0.05	10.41	134.19	14.80
P/FCF Ratio	-0.16	-0.03	-0.05	-0.33	-1.69	-4.19
P/OCF Ratio	-0.16	-0.03	-0.05	-0.34	-1.72	-4.20
EV/Sales Ratio	2.65	2.37	4.28	19.08	488.34	-
EV/EBITDA Ratio	-0.49	-2.68	-0.77	-1.18	-3.26	-4.80
EV/EBIT Ratio	-0.49	-2.42	-0.76	-1.17	-3.24	-4.77
EV/FCF Ratio	-10.81	-4.80	-1.02	-1.05	-2.03	-3.91
Debt / Equity Ratio	-0.64	-0.70	-0.99	24.41	63.80	0.01
Debt / EBITDA Ratio	-0.49	-2.70	-0.76	-0.87	-1.29	0.00
Debt / FCF Ratio	-10.82	-4.83	-1.01	-0.77	-0.80	0.00
Quick Ratio	0.07	0.09	0.04	0.10	0.65	1.93
Current Ratio	0.09	0.13	0.14	0.14	1.26	2.09
Asset Turnover	1.46	1.73	0.67	0.43	0.00	0
Interest Coverage	0	0	4.68	0	0	0
Return on Equity (ROE)	-76.52%	-85.56%	106.82%	-4328.95%	-10564.88%	-511.85%
Return on Assets (ROA)	614.87%	501.98%	-304.80%	-1066.65%	-129.41%	-282.85%
Return on Capital (ROIC)	72.45%	96.21%	12518.45%	-138.51%	-118.72%	-333.11%
Earnings Yield	7753.43%	17138.65%	-2039.84%	-415.79%	-78.73%	-34.59%
FCF Yield	-601.56%	-2902.43%	-1881.68%	-303.15%	-59.24%	-23.88%
Buyback Yield / Dilution	-2355.91%	-209270.21%	-571.43%	-75.00%	-100.00%	-71.23%
Total Shareholder Return	-2355.91%	-209270.21%	-571.43%	-75.00%	-100.00%	-71.23%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.